Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The primary efficacy endpoint for this study is the proportion of subjects with complete closure of Target Ulcer during the 20-week Treatment Phase, which is assessed by the blinded independent evaluator.
Epistemonikos ID: 3d7770b7f92afbcdbb8f4e42266b88bd426e1aa8
First added on: May 09, 2024